Strong Sensor Sales Growth and Recurring Revenue
Sensor sales increased ~40% in constant currencies; rolling 12‑month sensor volume grew ~27%. Company passed 1,000,000 monitored patients milestone, strengthening recurring revenue (sensors are the majority of revenues and drive gross margin leverage).
U.S. Disposable Performance and TetraGraph-as-a-Service Traction
U.S. disposables grew ~55% in local currency and overall U.S. business grew ~11% in local currency. Shipped 246 TetraGraphs in the U.S. during the quarter, of which 120 were deployed under the new TetraGraph‑as‑a‑Service model. First two As‑a‑Service deals closed in about half the time of a typical capital sale and support higher long‑term sensor margins.
Installed Base Expansion and Product Deliveries
Total shipped TetraGraphs surpassed ~5,500 units to date. Q1 shipments were 376 units (versus 443 prior year). Notable pediatric progress with 65 TetraGraphs delivered to pediatric operating rooms and a threefold increase in pediatric sensor units in the quarter.
Underlying Gross Margin Improvement
Underlying gross margin improved to ~69.2% (reported margin 63.1% after FX/tariff effects). Management is increasing pricing (U.S. ASPs up ~5%) and expects further margin expansion from scale and pricing actions.
Cost Discipline and Cash / Cash‑Flow Improvements
Operating expenses declined ~5% year‑over‑year and ~17.5% versus Q4. Operating cash flow improved ~33% (still negative), EBITDA slightly better, net earnings improved (partly FX driven). Cash of SEK 55.3m and access to additional credit (SEK ~42.5m available) provide runway.
Clinical Guideline Support and Product Innovation
Publication of new European pediatric guideline recommending quantitative (preferably EMG‑based) monitoring supports adoption. Launched TetraCom (EHR connectivity) enabling integration with Epic/Oracle and partners (Philips, Masimo, GE, Mindray), creating new monetization/recurring service opportunities.
Large Customer Wins and Strong Pipeline
Secured important U.S. wins including Ivy League hospitals, a major IDN expansion with ~SEK 6m run rate/year, a large hospital extension in Florida, a major children's hospital in Texas, and ~250 hospitals as customers in the U.S. Management reports a strong pipeline and maintains full‑year targets.